close

Lincare Holdings Inc., together with its subsidiaries, provides oxygen and other respiratory therapy services to the home health care market in the United States. The company provides home oxygen equipment that includes oxygen concentrators, the stationary units that provide continuous flow of oxygen by filtering ordinary room air; and liquid oxygen systems that are thermally insulated containers of liquid oxygen. It also offers respiratory therapy services, such as nebulizers and associated respiratory medications for customers suffering from chronic obstructive pulmonary disease (COPD) and asthma; continuous positive airway pressure devices that maintain open airways in customers suffering from obstructive sleep apnea by providing airflow at prescribed pressures during sleep; non-invasive ventilation, which provides nocturnal ventilatory support for customers with neuromuscular disease and COPD; and ventilators that support respiratory function in severe cases of respiratory failure. In addition, Lincare also provides various home infusion therapies, including parenteral nutrition, intravenous antibiotic therapy, enteral nutrition, chemotherapy, dobutamine infusions, immunoglobulin (IVIG) therapy, continuous pain management, and central catheter management. Further, the company supplies home medical equipment, such as hospital beds, wheelchairs, and other supplies. As of December 31, 2008, Lincare provided its products and services through 1,063 operating centers in 48 states. The company was founded in 1972 and is headquartered in Clearwater, Florida.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	27.03
Volume	282805
Volume Avg	629352
52 Week High	31.79
52 Week Low	19.65
PE	14.08
PE (group average)	39
EPS Year	1.93
EPS change Q/Q	2.04%
EPS change Q/Q Yr ago	8.7%
EPS change Q/Q next Q est	-9.09%
EPS change Y/Y	-20%
REV change Q/Q	2.25%
REV change Q/Q Yr ago	5.27%
EPS next Q est	0.55
EPS next Y est	2.35
Divident Annual	0.80
Dividend Yield	2.96%